|
Sam Harirforoosh, PharmD., Ph.D
is Assistant Professor in the Department of Pharmaceutical Sciences at
East Tennessee State University, Bill Gatton College of Pharmacy.
He coordinates and teaches Pharmacokinetics and Pharmacogenomics and
teaches portions of Pharmaceutics and Biopharmaceutics course.
Dr. Harirforoosh received his
Doctor of Pharmacy from Tehran University of Medical Sciences (Tehran,
Iran) in 1991, and his Ph.D. in Pharmaceutical Sciences
(Pharmacokinetics) in 2005 from the University of Alberta (Edmonton,
Canada). He served as a research assistant and a postdoctoral
fellow at the Pulmonary Research Group, University of Alberta from June
2005 to May 2006. He is also a registered pharmacist with the
Alberta College of Pharmacists.
Dr. Harirforoosh is a
member of American Association of Pharmaceutical Scientists, American
College of Clinical Pharmacology, American Association of Colleges of
Pharmacy, and Canadian Society for Pharmaceutical Sciences.
EDUCATION
-
2000-2005 -
Ph.D., Pharmaceutical Sciences (Pharmacokinetics), University of
Alberta
-
1986-1991 -
Pharm.D., Tehran University of Medical Sciences
PROFESSIONAL EXPERIENCE
| 2007 - Present |
Assistant
Professor
Dept. of Pharmaceutical Sciences
Bill Gatton College of Pharmacy
East Tennessee State University
Johnson City, TN
|
|
2005 - 2006 |
Research Assistant/Post-doctoral Fellow
Pulmonary Research Group
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada
|
|
2001- 2003 |
Teaching Assistant (Pharmaceutics)
Faculty of Pharmacy and Pharmaceutical Science
University of Alberta
Edmonton, Alberta, Canada
|
PHARMACY EXPERIENCE
| 2001 - 2007 |
Pharmacist
Edmonton, Alberta, Canada
|
| 1991 - 1998 |
Pharmacist
Iran
|
RESEARCH INTERESTS
-
Renal Effects of NSAIDs
-
Effect of Diseases on Pharmacokinetics and Pharmacodynamics of Drugs
-
Pharmacokinetics/Pharmacodynamics Modeling
PUBLICATIONS
|
Harirforoosh S,
Fleckenstein L, Mahajan P, Aruoma OI, Huang Y, Moridani M. The
importance of including topics related to pharmacogenetics,
pharmacogenomics and medical genetics in pharmacy curriculum. Am
J Pharm Educ (In Press). |
| |
|
Harirforoosh S,
Jamali F. Effect of inflammation on kidney function and
pharmacokinetics of COX-2 selective nonsteroidal
anti-inflammatory drugs rofecoxib and meloxicam. J Appl Toxicol
2008; 28(7):829-838. |
| |
|
Harirforoosh S,
Aghazadeh-Habashi A, Jamali F. Extent of renal effect of
cyclo-oxygenase-2-selective inhibitors is pharmacokinetic
dependent. Clin Exp Pharmacol Physiol 2006; 33(10):917-924. |
| |
|
Harirforoosh S,
Jamali F. Effect of nonsteroidal anti-inflammatory drugs with
varying extent of COX-2-COX-1 selectivity on urinary sodium and
potassium excretion in the rat. Can J Physiol Pharmacol 2005;
83(1):85-90. |
|